Anthracene derivatives as anti-cancer agents.

BTG International Ltd. (2004) Anthracene derivatives as anti-cancer agents. EP1087935 B1.

Full text not available from this repository. (Request a copy)


The present invention relates to compounds which are based on an anthraquinone nucleus for use in medicine, particularly as anti-cancer agents which exert their effects through their interaction with the activity of topoisomerases. The inhibition of DNA topoisomerases, particularly topoisomerase II (topo II) is now considered to be an important component in the mechanism of action of a large number of the most clinically active anticancer drugs presently available...

By "derivatives" of the compounds of the invention, we include salts (acid or base addition), esters, amides, hydrazides and hydroxamic acids of the group B and other derivatives which do not diminish to an unacceptable extent the fundamental topoisomerase mediated activity, ie. anti-tumour properties of the compounds. Further preferred derivatives include those in which functional groups on the peptide group, which may be side groups or the terminal group, are capped.

It is an object of this invention to provide improved clinically active anticancer agents preferably having one or more of the following properties: (i) reduced or eliminated capacity to induce generation of free radical species, (ii) reduced or eliminated capacity to bind to DNA or RNA, (iii) different relative activity against topoisomerases I, IIa and IIb (3 as compared to the known prior art compounds and (iv) activity, particularly being improved as compared to known compounds of this type, against drug resistant cell lines.

Compounds demonstrate non-cross resistant activity against resistant cell lines ... have broad spectrum activity and shrink MAC15A tumours in vivo in test animals. Furthermore, initial screening in the NCI screen shows compounds of the invention to be cytotoxic against NCI-H460 (lung), MCF7 (breast) and SF-268 (CNS) tumour lines.
It should be noted that while many of the results presented relate to trifluoroacetic acid salts, corresponding salts, eg. acetates, have been found to have equivalent activities.

Item Type: Patent
Related URLs:
Uncontrolled Keywords: Anthracene derivatives; Topoisomeraise inhibition; Anti-Cancer drugs; Free radical reduction; Toxicity reduction;
University Divisions/Research Centres: Faculty of Health, Life & Social Sciences > School of Life Sciences
Dewey Decimal Subjects: 600 Technology > 610 Medicine & health > 615 Pharmacology & therapeutics
500 Science > 540 Chemistry > 547 Organic chemistry
Library of Congress Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Item ID: 1680
Depositing User: RAE Import
Date Deposited: 09 Jul 2008 16:48
Last Modified: 23 Sep 2015 08:49

Actions (login required)

View Item View Item

Edinburgh Napier University is a registered Scottish charity. Registration number SC018373